The European Commission and the Pharmaceutical Inspection Co-operation Scheme (PIC/S) consulted on draft Annex 22, Artificial Intelligence. Here's what you should know.
- The EU Overhauls Pharma Laws: What You Need To Know
- Earlier Decisions, Better Processes Required For Automating Autologous CAR T Manufacturing
- Closing The CAR-T Access Gap With Hospital-Based Manufacturing
- How To Stand Up A Hospital-Based CAR-T Manufacturing Network
- September 2026 — CDMO Opportunities And Threats Report
- An Incomplete Response: Will The FDA Finish What It Started With Real-Time CRLs?
- Navigating Outsourced Pharmaceutical Testing Through Today's Geopolitical Uncertainty
- Is Your Supply Chain Ready For The End Of Class VI?
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Life Cycle Assessment Of Extended Use Strategies For Single-Use Assemblies
Examine how extending the use of single‑use assemblies can significantly reduce emissions, resource consumption, and waste in bioprocessing, offering a data‑backed path toward sustainability.
-
The Open Standard For Plug-And-Produce
Take a look at how standardized, modular production simplifies line integration, reduces engineering effort, and enables faster changeovers. Ideal for teams seeking flexible manufacturing models.
-
Raise Your Standards With Downflow Booth Airflow Containment
Ensure personnel safety during hazardous material handling by mastering airflow dynamics and containment screens. Learn to achieve low exposure levels through advanced HEPA filtration methods.
-
Phase-Appropriate Approaches To Manufacturing And Testing
Accelerate the development of high-quality biopharmaceuticals by implementing phase-appropriate, risk-based manufacturing and testing strategies that ensure timely progression.
-
Efficient Monitoring Of Escherichia Coli Feeding Strategies
Consistent, contamination-free sampling is critical for reliable bioprocess data. Automation enables frequent, hands-free collection, improving efficiency and insight while reducing manual workload.
-
Rescue Treatment Design In Wet AMD And Retinal Vascular Trials
How trials protect vision without muddying the data: explore the five design choices behind an effective rescue treatment strategy.
-
Automated Library Prep For A Nanopore DNA Barcoding Protocol
A streamlined workflow reduces reagent use and hands‑on time while preserving long‑read sequencing quality. See how multiplexed offer an efficient option for scaling or mobilizing sequencing efforts.
-
Challenges And Solution In The Poly (A) Control For Plasmid And mRNA
Poly(A) tail integrity is critical for mRNA stability and translation. Advanced strategies optimize plasmid design, transcription, and purification to ensure consistent poly(A) control for therapeutic success.
-
Ensuring Nuclease-Free Process Consumables For Biopharma Applications
Advanced therapies require strict contamination control. Learn how nuclease-free manufacturing, validation, and testing support quality, compliance, and reliable scale-up.
-
Rapid Production Of Assay Ready Cells For GPCR Drug Discovery
Accelerate drug discovery by leveraging transiently transfected assay-ready cells. This method improves assay sensitivity and reduces variability for GPCRs.
NEWSLETTER ARCHIVE
- 11.03.26 -- Where Speed Is Lost: Fixing Handoffs In BioPharma Operations
- 11.03.26 -- How Manufacturing Changes Can Create Risk For MSCs
- 11.03.26 -- Advancing CGT Delivery, Regulatory Strategy With Axiom's Dr. Remo Moomiaie-Qajar
- 11.02.26 -- Why Human-Relevant Models Are Reshaping Early Drug Discovery
- 11.02.26 -- How CGT Developers Should Think About Manufacturing Models, Hybrid Strategies, And Scale
- Earlier Decisions, Better Processes Required For Automating Autologous CAR T Manufacturing
- Why In Vivo Innovation, Regulatory Convergence Will Help Shape CGT's Next Chapter
- Inside The Next Phase In Autoimmune CAR T From Meeting On The Mesa 2026
- What LSPA's Life Sciences Future Says About The Road Ahead For CGT
- Inside Scaling Next-Gen MSCs Without Scaling Risk
EDITORIAL COLLECTIONS KNOWLEDGE CENTER
Our Editorial Collections examine today’s biggest scientific, operational, and patient-centered drug delivery issues. These collections help companies navigate complex development decisions with in-depth analysis, real-world examples, and guidance from industry experts
More Editorial Collections

